Pontifax Venture Capital is a venture capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in Herzliya, Israel. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.
Pontifax Venture Capital funds companies at various stages of development, from early stage to growth capital. It specializes in funding companies that are based in Israel. The firm prefers to fund companies operating in the pharmaceutical and life science industry sectors. Since January 2016, the firm has managed to raise $585 million through three funding rounds. Its most recent funding round was held in November 2018, amassing $170 million.
Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.
A company focused on delivering cure for cancer using engineered T cell therapy
Prevail Therapeutics is a New York City-based company.
Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug.
LogicBio Therapeutics is a Cambridge, Massachusetts-based company.
89Bio is a San Francisco-based company.
Associated investment funds
Chief Executive Officer/Founder
Documentaries, videos and podcasts